Pan-European Switzerland-based lab group Unilabs has finalised the acquisition of a smaller French competitor, Biopath, for what we think is the highest multiple the consolidating French lab market has seen so far. Healthcare Europa names the price.
A big lab group appears to have cracked the key to making money from B2C tests and is already selling hundreds of thousands such tests a year online. That would be quite an achievement. We name names.
Last week Healthcare Nova reported that US-based lab company Quest Diagnostics had sold its Indian medical diagnostics arm to Strand Life Sciences. We also reported that Quest has set up an international alliance of lab companies based in Brazil, Saudi Arabia, Korea, Hong Kong and Australia. Are the two moves connected? We speak to Quest's MD of global markets, Mark Machulcz to find out more about the group's change of strategy.
European lab group Cerba has continued to hoover up French labs, acquiring smaller rival Accolab from private equity firm LFPI Gestion. We name the price.
Medicover's lab arm Synevo has acquired the Ukrainian diagnostics operations of Russian lab group Invitro for €6m, further sealing its dominant position.
Specialist diagnostics lab company Strand Lifesciences has bought the Indian medical diagnostics arm of Quest Diagnostics. Healthcare Nova speaks to its CEO about the deal, and how the two companies will continue working together going forward.
Some of the largest lab groups in the world have banded together to form the "Global Diagnostics Network", an international alliance led by US-lab giant Quest Diagnostics.
The consolidation of the French lab market continues as Swiss diagnostic labs group Unilabs has acquired Biopath and its 39 labs in France, along with two smaller regional players.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.